Needham, United States
BBK Worldwide, with its slogan "Transforming the Clinical Trial Patient Experience," is a pioneering entity in the patient recruitment industry. Founded in 1983, the company has dedicated 40 years to innovating patient recruitment and engagement processes through its patented technology, TrialCentralNet®. This technology provides comprehensive solutions aimed at accelerating clinical trial enrollment and enhancing diversity, equity, and inclusion.
The company's leadership, comprised of founders Joan F. Bachenheimer and Bonnie A. Brescia, reflects a longstanding commitment to patient advocacy and patient-centric care. Located in the United States, BBK Worldwide joined forces with Publicis Health in January 2022, a strategic alliance that underscores its dedication to advancing the clinical trial landscape.
BBK Worldwide has not recently disclosed investment rounds or investor engagement, which may indicate a self-sustaining growth model or a focus on strategic partnerships to fuel its continued expansion in a competitive industry.
